InMed Pharmaceuticals Inc. (US:INM)
Report Summary
| Title | Details |
|---|---|
| Date Range | 04/21/2022 to
05/20/2022 |
| Company Landing Page | https://biotechmarketreporter.com/forefront-of-development-manufacturing-and-commercialization-of-rare-cann-a-binoids/ |
| Average Time on Page | 3:09 |
| Scroll Depth | 73% |
AD SPEND DETAILS
Total Unique
Investor Visits: 808,638
Total
Ad Spend: $129,379
DEMOGRAPHICS
Age
Gender
NOTES
Second Clicks to Landing Page:
INM = 67K (8.03%)
Retargeting List: 250K
Ty Hoffer
TY@LIFEWATERMEDIA.COM
281-804-7972